Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673506 | SCV000798715 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-03-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005091960 | SCV005743656 | pathogenic | not provided | 2024-02-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp2237Tyrfs*39) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 557372). For these reasons, this variant has been classified as Pathogenic. |